Rocco F. Tarasi III, serving as the Chief Marketing Officer for CNO Financial Group, Inc. (NASDAQ:CNO), completed a transaction involving the sale of 1,891 shares of the company's common stock on July 1, 2026. The aggregate value of this divestment was approximately $97,027, executed at a per-share price of $51.31. Post-transaction, Tarasi maintains a direct holding of 77,300 shares of CNO Financial Group common stock.
This sale activity unfolds against a backdrop of robust stock performance for CNO Financial Group. The shares were trading at $52.09, a valuation level proximate to the 52-week high of $53.03. Over the preceding twelve months, the stock has generated a substantial return of 33.84%. The company's market capitalization stands at $4.88 billion, with a price-to-earnings (P/E) ratio of 20.9. The transaction was facilitated under a Rule 10b5-1 trading plan, which was formally adopted on February 24, 2026.
Market analysis from InvestingPro indicates that CNO is currently trading in close alignment with its Fair Value. The company has established a consistent track record of increasing its dividend for 14 consecutive years, a factor that contributes to its strong price momentum. For investors seeking more granular data, the platform provides 9 additional ProTips and comprehensive analysis via its Pro Research Report.
In parallel with the executive transaction, CNO Financial Group reported financial results for the first quarter of 2026 that surpassed consensus estimates. The company recorded earnings per share (EPS) of $1.05, outperforming the forecasted $0.94. Revenue also exceeded projections, reaching $1.03 billion compared to the anticipated $1.01 billion. These figures highlight a period of positive financial performance for the organization.
External analyst sentiment has also shifted. Evercore ISI upgraded the stock rating for CNO Financial Group from Underperform to In Line. The upgrade was driven by the firm's analysis of long-term care statutory data. Concurrently, the price target was raised to $48 from $43, reflecting a narrower long-term care discount. At the company's recent annual meeting, shareholders demonstrated confidence in the current leadership by electing nine directors to one-year terms. Each nominee received substantial votes in favor with minimal opposition, signaling ongoing strategic alignment within the group.